UTHSC In the Media


‘The work of a frontiersman never stops’ | Gov. Bill Lee outlines ambitious budget in 2026 State of the State Address

In the Media Icon

Gov. Bill Lee’s final State of the State address unveiled a $57.9 billion budget centered on nuclear and economic growth, educational freedom and public safety.


Music and The Brain: A Musician Neurologist’s Perspective

In the Media Icon

Andrew Wilner is a professor of neurology at the University of Tennessee Health Science Center, Memphis, and a seasoned neurologist and epilepsy expert who has mastered the less conventional locum career path.


Nonprofit blood bank hosting blood drives throughout Mid-South

In the Media Icon

A nonprofit blood bank is searching for blood donors and needs the community’s help in saving lives.


Erlanger Health System Achieves Strong Results in Robotic Access and OR Capacity with Qventus, On Track to Deliver 5x Annualized ROI

In the Media Icon

Qventus’ Surgical Growth Solution secured 220 additional surgical cases per month, achieving break-even across all sites in less than three months


Erlanger Health System Achieves Strong Results in Robotic Access and OR Capacity with Qventus, On Track to Deliver 5x Annualized ROI

In the Media Icon

Qventus, the industry’s leading provider of AI-based care operations automation software, today announced strong results from its partnership with Erlanger, a nationally-acclaimed, multi-hospital health system.


McCoy named assistant dean of HCOP Mobile Campus

In the Media Icon

Following an internal search, Dr. Emily McCoy, associate clinical professor in the Department of Pharmacy Practice, has been named Assistant Dean of the Harrison College of Pharmacy’s Mobile Campus.


A stable for the Sheriff’s Office mounted-patrol unit. A bomb-squad robot. A new county medical examiner.

In the Media Icon

The Shelby County Board of Commissioners votes Monday, Feb. 2, on Dr. Scott Collier’s appointment by County Mayor Lee Harris as Shelby County medical examiner.


Aquestive Therapeutics Announces FDA Issuance of Complete Response Letter for Anaphylm™

In the Media Icon

Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients’ lives through innovative science and delivery technologies, today announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) on January 30, 2026 for the New Drug Application (NDA)… Read More